GlaxoSmithKline KK said Friday that it plans to ship enough of its Relenza to treat 13.5.million people in Japan this flu season in response to the growing number of A/H1N1 influenza infections. ... www.nni.nikkei.co.jp/e/fr/tnks/Nni20090911D11JFNO.htm I believe Glaxo got the order . The only question is, has Glaxo the capacity for a shipment of this quantity until March 2010. The global demand is growing. 12,5 mill. units Relenza = 20-25 m Austr.Dollar royalties. Not bad !
With best wihes from Germany !
BTA Price at posting:
$2.17 Sentiment: None Disclosure: Not Held
